Risk Factors for Severe Infections in Rituximab Treated Patients: Comparison of Systemic Lupus Erythematosus and Inflammatory Myositis

被引：0
|
作者：
Medeiros, Cristiane [1 ]
Seguro, Luciana [2 ]
Carlos de Souza, Fernando Henrique [2 ,3 ]
Aikawa, Nadia E. [3 ]
Bonfa, Eloisa [2 ]
机构：
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Rheumatol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Rheumatol Div, Hosp Clin, Fac Med, Sao Paulo, Brazil
[3] Univ Sao Paulo, Pediat Rheumatol, Hosp Clin, Fac Med, Sao Paulo, Brazil
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
773
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Myelofibrosis associated with systemic lupus erythematosus successfully treated with rituximab
    Kaul, A.
    Horwood, N.
    Kotecha, J.
    LUPUS, 2019, 28 (13) : 1612 - 1614
  • [42] Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
    Karimifar, Mansoor
    JOURNAL OF RENAL INJURY PREVENTION, 2012, 1 (02): : 53 - 54
  • [43] Risk factors for initial and recurrent severe infections in first hospitalized patients with systemic lupus erythematosus: A retrospective study of a Chinese cohort
    Zhu, Ying
    Zhu, Kexin
    Zhang, Xueyi
    Qian, Zhijie
    Guo, Qingqing
    Xu, Xuefeng
    Yao, Genhong
    Tang, Xiaojun
    Wang, Dandan
    Zhang, Huayong
    Feng, Xuebing
    Jin, Ziyi
    Sun, Lingyun
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (04)
  • [44] Infections Observed in Rituximab Treated Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
    McCarthy, Eoghan M.
    Sutton, Emily
    Isenberg, David A.
    Rahman, Anisur
    Rhodes, Benjamin
    Hewins, Peter
    McHugh, Neil J.
    Parker, Ben
    Griffiths, Bridget
    Lanyon, Peter
    Vital, Edward M.
    Teh, Lee-Suan
    Akil, Mohammed
    Youssef, Hazem
    D'Cruz, David P.
    Khamashta, Munther
    Erb, Nicola
    Jayne, David
    Edwards, Christopher J.
    Prabu, Athiveer
    Batley, Michael
    Gendi, Nagui
    Dasgupta, Bhaskar
    Stratton, Richard J.
    Yee, Chee-Seng
    Zoma, Asad
    Gordon, Caroline
    Chan, Antoni
    Min, Steven Young
    Dubey, Shirish
    King, Jon
    De Lord, Denise
    O'Riordan, Edmond
    Jeffery, Rachel
    Hassan, Waji
    Regan, Marian
    Bruce, Ian N.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] Associated clinical factors for serious infections in patients with systemic lupus erythematosus
    Ju-Yang Jung
    Dukyong Yoon
    Young Choi
    Hyoun-Ah Kim
    Chang-Hee Suh
    Scientific Reports, 9
  • [46] Associated clinical factors for serious infections in patients with systemic lupus erythematosus
    Jung, Ju-Yang
    Yoon, Dukyong
    Choi, Young
    Kim, Hyoun-Ah
    Suh, Chang-Hee
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] FACTORS ASSOCIATED WITH INFECTIONS AMONG PEDIATRIC PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED AT INTENSIVE CARE UNITS
    Restrepo-Escobar, M.
    Rios, N. A.
    Hernandez-Zapata, L. J.
    Velasquez, M.
    Quevedo, A.
    Eraso, R.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S127 - S127
  • [48] 1009 Rituximab in Systemic Lupus Erythematosus in Pediatric Patients
    M M Rodrigues
    P Oliveira
    C Simão
    Pediatric Research, 2010, 68 : 502 - 502
  • [49] EFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ren, Y.
    Wang, L.
    An, Z.
    Yang, L.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1477 - 1477
  • [50] Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
    R Martínez-Pérez
    A Fernández-Nebro
    M López-Lasanta
    M L Velloso-Feijoo
    A Muñoz-Jiménez
    J López Longo
    J L Marenco
    Journal of Translational Medicine, 8 (Suppl 1)
12345